Obesity is associated with the Optic Neuritis severity in Male patients with Multiple Sclerosis.

Autor: Chu DT; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Massachusetts, US; Harvard Medical School, Boston, Massachusetts, US., Rosso M; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Massachusetts, US; Harvard Medical School, Boston, Massachusetts, US., Gonzalez CT; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Massachusetts, US; Harvard Medical School, Boston, Massachusetts, US., Saxena S; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Massachusetts, US; Harvard Medical School, Boston, Massachusetts, US., Healy BC; Harvard Medical School, Boston, Massachusetts, US; Massachusetts General Hospital Biostatistics Center, Boston, Massachusetts, US; Partners Multiple Sclerosis Center, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, US., Weiner HL; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Massachusetts, US; Harvard Medical School, Boston, Massachusetts, US; Partners Multiple Sclerosis Center, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, US., Chitnis T; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Massachusetts, US; Harvard Medical School, Boston, Massachusetts, US; Partners Multiple Sclerosis Center, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, US. Electronic address: tchitnis@rics.bwh.harvard.edu.
Jazyk: angličtina
Zdroj: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2021 Jun; Vol. 51, pp. 102910. Date of Electronic Publication: 2021 Mar 21.
DOI: 10.1016/j.msard.2021.102910
Abstrakt: Background: Obesity is an important modifiable risk factor of MS; a deeper biological understanding of this association is needed.
Objective: To evaluate the determinants of acute optic neuritis (AON) severity and recovery in multiple sclerosis (MS).
Methods: We included 61 patients with MS with recorded AON severity and recovery according to visual acuity outcomes before, at, and, after the relapse. We measured body mass index (BMI) and the serum concentration of estrogen, leptin, testosterone, sex hormone-binding globulin, and vitamin D. We tested the association between BMI and serum hormones and AON severity and recovery with logistic regressions.
Results: In males, moderate/severe AON was associated with higher BMI (31.26 kg/m 2 vs 25.73 kg/m 2 , logistic regression, p= 0.03), higher serum estrogen levels (32.24 nmol/L vs 23.06 nmol/L, logistic regression, p=0.04), and higher serum leptin levels (12.29 ng/mL vs mild AON: 4.1 ng/mL, logistic regression, p=0.06) than mild AON. These observations were not seen in female patients. We did not find an association with BMI or hormone levels and AON recovery.
Conclusion: BMI, serum leptin, and serum estrogen were associated with AON severity in male patients but not in female patients. No association of these factors and AON recovery was observed.
(Copyright © 2021. Published by Elsevier B.V.)
Databáze: MEDLINE
Externí odkaz: